Loading clinical trials...

The Kilimanjaro Cervical Screening Project | Clinical Trials | Clareo Health

COMPLETEDNA

The Kilimanjaro Cervical Screening Project

NCT01968837•Queen's University

Summary

Although highly curable, cervical cancer kills thousands of women in developing countries annually. The investigators will pilot a project to improve detection of cervical cancer in Kilimanjaro, Tanzania through a program that combines access to cervical screening expertise available in a large medical centre and remote use of a mobile phone camera application.

Eligibility

Age

25 - 49 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Female
•Over 18 years of age

Exclusion Criteria

•Previous removal of uterus

Locations (1)

Reproductive Health Centre, KCMC

Moshi, Tanzania

Key Dates

Start Date

May 1, 2014

Primary Completion Date

September 1, 2015

Completion Date

September 1, 2015

Last Updated

April 13, 2016

Enrollment

1,072

ACTUAL participants

Conditions

Uterine Cervical NeoplasmsCervical Cancer

Interventions

Cervical cancer screening

OTHER

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

NCT06349642

Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial Carcinoma+25 more

View study

RECRUITINGPHASE1/PHASE2

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

NCT05639972

HPV-Associated Cervical CarcinomaHPV-Related Carcinoma+15 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 13, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Kilimanjaro Cervical Screening Project

Inclusion Criteria

Exclusion Criteria

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Rice Technologies for Cervical Cancer Screening and Diagnosis